Although research has revealed that many genes are subject to RNA m6A modification and thus participate in tumor progression [23], to date, there have been no reports on the relationship between DLG2 and RNA m6A modification, or on whether DLG2 can influence the malignant phenotype of cervical cancer through this pathway. The gene discussed is DLG2; the disease is cervical cancer.